Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

May 21, 2013

30339_dirs_2013-05-21_ade016f8-2056-4aac-b62a-2b4894fa1e9a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-05-14

Reporting Person: JOHNSON L ROBERT (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-14 Common Stock G 590.0000 $0.0000 Disposed 27521.9300 Direct
2013-05-15 Common Stock G 470.0000 $0.0000 Disposed 27051.9300 Direct
2013-05-20 Common Stock G 75.0000 $0.0000 Disposed 22976.9300 Direct